Breaking News

Cryoport to Support ProMab’s CAR-T Services

Will provide cryogenic logistics services to support ProMab's new CAR-T cells

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cryoport, Inc will be providing its cryogenic logistics services to support ProMab Biotechnologies‘ new chimeric-antigen receptors (CARs), and specifically CAR-redirected T-cells (CAR-T). ProMab is generating CAR-T cells for use in research and preclinical studies, and as a clinical tool, with development and manufacturing activities in the U.S. and China. ProMab will employ Cryoport’s cryogenic logistics solutions for the movement of biologic materials throughout China. ProMab ha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters